APA

Ericsson H., Hamrén B., Bergstrand S., Elebring M., Fryklund L., Heijer M. & Ohman K. P. (20050623). Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans. : Drug metabolism and disposition: the biological fate of chemicals.

Chicago

Ericsson H, Hamrén B, Bergstrand S, Elebring M, Fryklund L, Heijer M and Ohman K P. 20050623. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans. : Drug metabolism and disposition: the biological fate of chemicals.

Harvard

Ericsson H., Hamrén B., Bergstrand S., Elebring M., Fryklund L., Heijer M. and Ohman K. P. (20050623). Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans. : Drug metabolism and disposition: the biological fate of chemicals.

MLA

Ericsson H, Hamrén B, Bergstrand S, Elebring M, Fryklund L, Heijer M and Ohman K P. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans. : Drug metabolism and disposition: the biological fate of chemicals. 20050623.